SinoMab BioScience Limited carries a market capitalization of 1.29B, placing it among publicly traded companies globally.
| Market Cap | 1.29B |
| Enterprise Value | N/A |
SinoMab BioScience Limited's stock has declined approximately -41.14583% over the past 52 weeks. The 50-day moving average sits at 1.26, while the 200-day moving average is 1.56.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.14583% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 1.56 |
| Average Volume (20 Days) | N/A |